StockData
Mesoblast Ltd logo

Mesoblast Ltd (MESO) stock

MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)

Close on Nov 17, 2026Market cap $1.54BP/E –Yield –

Mesoblast EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Mesoblast's EPS for the twelve months ending Jun 30, 2023 was -$0.11. For fiscal 2026 it was -$0.04. The highest annual figure on record is -$0.01 in fiscal 2016.

Annual eps

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$0.04–
FY2025Jun 30, 2025-$0.08–
FY2024Jun 30, 2024-$0.09–
FY2023Jun 30, 2023-$0.11–
FY2022Jun 30, 2022-$0.13–
FY2021Jun 30, 2021-$0.16–
FY2020Jun 30, 2020-$0.15–
FY2019Jun 30, 2019-$0.18–
FY2018Jun 30, 2018-$0.08–
FY2017Jun 30, 2017-$0.19–
FY2016Jun 30, 2016-$0.01–

Quarterly eps

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ2 2023Jun 30, 2023-$0.02–
Q3 FY2023CQ1 2023Mar 31, 2023-$0.03–
Q2 FY2023CQ4 2022Dec 31, 2022-$0.03–
Q1 FY2023CQ3 2022Sep 30, 2022-$0.02–
Q4 FY2022CQ2 2022Jun 30, 2022-$0.03–
Q3 FY2022CQ1 2022Mar 31, 2022-$0.03–
Q2 FY2022CQ4 2021Dec 31, 2021-$0.04–
Q1 FY2022CQ3 2021Sep 30, 2021-$0.03–
Q3 FY2021CQ1 2021Mar 31, 2021-$0.04–
Q2 FY2021CQ4 2020Dec 31, 2020-$4.38–
Q1 FY2021CQ3 2020Sep 30, 2020-$4.21–
Q3 FY2020CQ1 2020Mar 31, 2020-$2.84–
Q2 FY2020CQ4 2019Dec 31, 2019-$4.60–
Q1 FY2020CQ3 2019Sep 30, 2019-$1.10–
Q4 FY2019CQ2 2019Jun 30, 2019-$0.04–
Q3 FY2019CQ1 2019Mar 31, 2019-$0.05–
Q2 FY2019CQ4 2018Dec 31, 2018-$0.05-271.8%
Q1 FY2019CQ3 2018Sep 30, 2018-$0.04–
Q4 FY2018CQ2 2018Jun 30, 2018-$0.04–
Q3 FY2018CQ1 2018Mar 31, 2018-$0.04–
Q2 FY2018CQ4 2017Dec 31, 2017$0.03–

More Mesoblast figures

See a number that looks wrong?